Labetalol
- Generic Name
- Labetalol
- Brand Names
- Trandate
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2O3
- CAS Number
- 36894-69-6
- Unique Ingredient Identifier
- R5H8897N95
Overview
Labetalol is a racemic mixture of 2 diastereoisomers where dilevalol, the R,R' stereoisomer, makes up 25% of the mixture. Labetalol is formulated as an injection or tablets to treat hypertension. Labetalol was granted FDA approval on 1 August 1984.
Background
Labetalol is a racemic mixture of 2 diastereoisomers where dilevalol, the R,R' stereoisomer, makes up 25% of the mixture. Labetalol is formulated as an injection or tablets to treat hypertension. Labetalol was granted FDA approval on 1 August 1984.
Indication
Labetalol injections are indicated to control blood pressure in severe hypertension. Labetalol tablets are indicated alone or in combination with antihypertensives like thiazides and loop diuretics to manage hypertension.
Associated Conditions
- Chronic Stable Angina Pectoris
- Hypertension
- Hypertensive Emergency
- Hypertensive crisis
- Pheochromocytoma
- Subarachnoid Hemorrhage
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.